Skip to main content
Clinical Trials/ISRCTN13188211
ISRCTN13188211
Active, not recruiting
Phase 2

Investigating the effect of nasal spray with extract of licorice on treatment of allergic rhinitis

Chiayi Chang Gung Memorial Hospital0 sites120 target enrollmentSeptember 1, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Treatment of patients with allergic rhinitis
Sponsor
Chiayi Chang Gung Memorial Hospital
Enrollment
120
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2022
End Date
August 31, 2025
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chiayi Chang Gung Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with allergic rhinitis; the diagnostic criteria require a visual analogue scale (0\-100\) in the four categories of sneezing, itchy nose, rhinorrhea and nasal obstruction with a summed score greater than 120, and immunoglobulin E greater than 120 kU/L, and more than one inhalation allergen, such as dust.

Exclusion Criteria

  • 1\. Patients aged less than 20 years
  • 2\. A history of allergy to licorice or corticosteroid
  • 3\. Pregnancy
  • 4\. A history of malignancies of the sinuses or nasopharynx
  • 5\. Patients who had undergone turbinate, septum or sinus surgery
  • 6\. If steroids or antihistamines is used in the month prior to inclusion, one month of cessation is required to conduct the trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials